Please login to the form below
Eladynos
This page shows the latest Eladynos news and features for those working in and with pharma, biotech and healthcare.
CHMP backs first-line use for AZ’s Tagrisso in lung cancer
The three drugs in question are Portola’s anticagulant Dexxience (betrixaban), Radius’ osteoporosis candidate Eladynos (abaloparatide) and AB Science’s Alsitek (masitinib), filed for neurodegenerative disease amyotrophic lateral sclerosis (ALS)
Latest news
-
ViiV’s two-drug HIV combo backed by CHMP
There was bad news for three other companies, with the CHMP issuing negative opinions for Portola’s Dexxience (betrixaban) for the prevention of venous thromboembolism, Radius International’s osteoporosis candidate Eladynos
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- PHE study finds people who have had COVID-19 can still transmit the virus
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- UK pharmacies to begin administering COVID-19 vaccinations
- J&J could launch its single-dose COVID-19 vaccine in March
- AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
- Future-Proofing Healthcare and Medicine
- AI in Computer Vision Technology and the Impact on Healthcare
- Lateral flow tests detect ‘most infectious’ COVID-19 cases, Oxford researchers find
- Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance
- Pfizer/BioNTech's COVID-19 vaccine found to be effective against UK virus variant
- BMS aims for US approval of Opdivo combo in stomach cancer
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- The pandemic preparedness paradox
- Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- Recent years have seen a significant shift in drug development to specialty areas...
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Quick links
Infographics
